标题
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
作者
关键词
-
出版物
Nature Chemical Biology
Volume 10, Issue 10, Pages 853-860
出版商
Springer Nature
发表日期
2014-09-08
DOI
10.1038/nchembio.1629
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?
- (2014) Zheng Zhao et al. ACS Chemical Biology
- Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies
- (2014) Apirat Chaikuad et al. BIOCHEMICAL JOURNAL
- Copper is required for oncogenic BRAF signalling and tumorigenesis
- (2014) Donita C. Brady et al. NATURE
- Conformation-Selective Inhibitors Reveal Differences in the Activation and Phosphate-Binding Loops of the Tyrosine Kinases Abl and Src
- (2013) Sanjay B. Hari et al. ACS Chemical Biology
- Sequence Determinants of a Specific Inactive Protein Kinase Conformation
- (2013) Sanjay B. Hari et al. CHEMISTRY & BIOLOGY
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- (2013) Georgia Hatzivassiliou et al. NATURE
- ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
- (2013) Ana Rita Carlos et al. Nature Communications
- A Genome-Scale RNA Interference Screen Implicates NF1 Loss in Resistance to RAF Inhibition
- (2013) Steven R. Whittaker et al. Cancer Discovery
- Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
- (2013) E. J. Morris et al. Cancer Discovery
- Discovery of Checkpoint Kinase Inhibitor (S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by Structure-Based Design and Optimization of Thiophenecarboxamide Ureas
- (2012) Vibha Oza et al. JOURNAL OF MEDICINAL CHEMISTRY
- ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- (2012) G. Hatzivassiliou et al. MOLECULAR CANCER THERAPEUTICS
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- (2012) Ryan B. Corcoran et al. Cancer Discovery
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
- (2011) Katharina Schlacher et al. CELL
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- Understanding the Impact of the P-loop Conformation on Kinase Selectivity
- (2011) Cristiano R. W. Guimarães et al. Journal of Chemical Information and Modeling
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design
- (2011) Peter Schmidtke et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Expressing the human proteome for affinity proteomics: optimising expression of soluble protein domains and in vivo biotinylation
- (2011) Tracy Keates et al. New Biotechnology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors
- (2010) Jianming Zhang et al. NATURE
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function
- (2010) Nicholas Kwiatkowski et al. Nature Chemical Biology
- Rad51 protects nascent DNA from Mre11-dependent degradation and promotes continuous DNA synthesis
- (2010) Yoshitami Hashimoto et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control
- (2009) Alex M. Aronov et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure and functional characterization of the atypical human kinase haspin
- (2009) J. Eswaran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein Phosphorylation
- (2009) Alex N. Bullock et al. STRUCTURE
- Crystal structure of human mono-phosphorylated ERK1 at Tyr204
- (2008) Takayoshi Kinoshita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signaling
- (2008) Lore M. Gruenbaum et al. BIOCHEMICAL PHARMACOLOGY
- Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
- (2008) B. Evers et al. CLINICAL CANCER RESEARCH
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now